The reporter learned at the "National Science and Technology Major Special Project for New Drug Creation" results conference held by the Ministry of Science and Technology on the 22nd that my country has broken the foreign drug monopoly in lung cancer, leukemia, drug-resistant bacteria and other fields, and the biomedical industry's R&D and innovation capabilities and industrial development continue Enhancement, achieved stage results, and achieved fruitful results.
Drug issues are related to people's lives and health, and there have been painful lessons all over the world. Non-clinical evaluation is an important part of the necessary stage of new drug development. Sang Guowei, chief technical engineer of the new drug creation project and academician of the Chinese Academy of Engineering, said that with the support of the new drug creation project, my country's drug non-clinical evaluation platform has made a series of major breakthroughs. The pre-clinical evaluation work of new drugs has been in line with international standards. The core of the evaluation platform The key technology has reached the international advanced level, which strongly supports the research and development of new drugs in my country and guarantees the use of drugs by the public.